Cracking Japan’s Pharma Ecosystem: Field Notes from ~20 Years in the Trenches Japan rewards sequencing, proof, […]
As mRNA biotechnology matures, few firms have demonstrated a shift as dynamic as Moderna. Widely recognised […]
In the mid-1990s, Japan was not merely participating in the global pharmaceutical industry—it was shaping it. […]
Japan presents a unique landscape for pharmaceutical companies, both domestic and international. The recent study published […]
The recent regulatory changes in Japan’s pharmaceutical sector present a significant opportunity for non-Japanese companies. By […]
Japan’s Bioeconomy Strategy 2030 marks a transformative approach to integrating biotechnology into Japan’s economic fabric. It’s […]
Once a flourishing beacon of innovation and global leadership, Japan’s pharmaceutical industry has encountered significant headwinds […]
Japan is a beacon of innovation globally, especially in the pharmaceutical sector. Notably, the rise of […]